Package 68083-412-10

{"route": ["INTRAVENOUS"], "spl_id": "706b6332-5afe-498b-a846-788e6ebc6823", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143"], "unii": ["6AQ1Y404U7"], "rxcui": ["1656056"], "spl_set_id": ["c86264c2-ef49-4524-b6af-edb7a6279faa"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]"], "manufacturer_name": ["Gland Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-DOSE in 1 CARTON (68083-412-10)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE", "package_ndc": "68083-412-10", "marketing_start_date": "20250811"}], "brand_name": "Cangrelor", "product_id": "68083-412_706b6332-5afe-498b-a846-788e6ebc6823", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Decreased Platelet Aggregation [PE]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "68083-412", "generic_name": "Cangrelor", "labeler_name": "Gland Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cangrelor", "active_ingredients": [{"name": "CANGRELOR", "strength": "50 mg/1"}], "application_number": "ANDA213551", "marketing_category": "ANDA", "marketing_start_date": "20250811", "listing_expiration_date": "20261231"}